$3.52
-0.02-0.56%
Last update: Nov 10, 7:51 PM
Aquestive Therapeutics Inc
AQSTNASDAQ
The average analyst price target for Aquestive Therapeutics is $9.90, 180.6% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $7 to $17. The latest change came on Nov 7, 2025, when Piper Sandler raised its price target on Aquestive Therapeutics from $5 to $8 and kept an Overweight rating.
Price Target Range — 9 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
